Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Psychiatry
•
Behavioral Neurology & Neuropsychiatry
Is there sufficient evidence yet to support the use of lithium supplementation or prescription in the management of neurodegenerative diseases?
Would you consider it in a patient with strong familial risk of early onset NDD?
Related Questions
How do you manage problematic disinhibited behaviors in patients with neurocognitive disorders?
What is your approach to the management of transfusion reactions with lecanemab, both in the immediate setting and with respect to the prevention of reactions with future infusions?
How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?
What are the limits and standalone value of volumetric MRI for the preclinical evaluation of dementia?
When do you suspect an autoimmune encephalitis in a child or adolescent with new-onset psychosis?
How do you treat agitation in progressive supranuclear palsy?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?
When is it useful to test for multiple amyloid-related biomarkers for patients undergoing work-up for cognitive impairment?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
How do you approach the management of behavioral disturbance/aggression in patients with a recent traumatic brain injury?